---
title: "NRSN.US (NRSN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NRSN.US/news.md"
symbol: "NRSN.US"
name: "NRSN.US"
parent: "https://longbridge.com/en/quote/NRSN.US.md"
datetime: "2026-03-09T11:20:37.383Z"
locales:
  - [en](https://longbridge.com/en/quote/NRSN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NRSN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NRSN.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NRSN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NRSN.US/news.md)


# NRSN.US (NRSN.US) — Related News

### [17:31 ETDrug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight](https://longbridge.com/en/news/276796435.md)
*2026-02-24T22:32:17.000Z*
> DelveInsight forecasts significant growth in the drug-resistant epilepsy market from 2025 to 2034, driven by rising prev

### [Pre-market hot trades in US stocks: NeuroSense Therapeutics - Unit up 7.84% in pre-market; Super Micro Computer up 4.64% in pre-market](https://longbridge.com/en/news/276339926.md)
*2026-02-19T13:42:43.000Z*
> NeuroSense Therapeutics - Unit pre-market up 7.84%; Super Micro Computer pre-market up 4.64%; Rubico pre-market up 73.21

### [](https://longbridge.com/en/news/276256032.md)
*2026-02-18T17:15:08.000Z*
> NeuroSense Therapeutics shares are trading lower. The company announced the availability of additional long-term surviva

### [05:30 ETLenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study](https://longbridge.com/en/news/276112637.md)
*2026-02-17T10:30:40.000Z*
> Lenire, the only FDA-approved tinnitus treatment device, has shown consistent positive results in a second peer-reviewed

### [NeuroSense secures Australian patent for PrimeC till 2042, enhancing global IP for severe neurodegenerative diseases.](https://longbridge.com/en/news/275333574.md)
*2026-02-09T14:22:06.000Z*
> NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) based in Cambridge, Mass., has expanded its worldwide intellectual property 

### [NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition | NRSN Stock News](https://longbridge.com/en/news/275331547.md)
*2026-02-09T06:20:00.000Z*
> NeuroSense Therapeutics Ltd. has been granted an Australian patent for its PrimeC composition, enhancing its global inte